270 related articles for article (PubMed ID: 11310635)
1. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis.
Stefan K; Kunesch E; Benecke R; Classen J
Ann Neurol; 2001 Apr; 49(4):536-9. PubMed ID: 11310635
[TBL] [Abstract][Full Text] [Related]
2. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
4. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.
Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W
J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657
[TBL] [Abstract][Full Text] [Related]
5. The cortical silent period and amyotrophic lateral sclerosis.
Prout AJ; Eisen AA
Muscle Nerve; 1994 Feb; 17(2):217-23. PubMed ID: 8114792
[TBL] [Abstract][Full Text] [Related]
6. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
Roch-Torreilles I; Camu W; Hillaire-Buys D
Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
[TBL] [Abstract][Full Text] [Related]
7. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
8. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
9. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
[TBL] [Abstract][Full Text] [Related]
10. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis associated with pregnancy.
Tyagi A; Sweeney BJ; Connolly S
Neurol India; 2001 Dec; 49(4):413-4. PubMed ID: 11799421
[TBL] [Abstract][Full Text] [Related]
12. An association study of riluzole serum concentration and survival and disease progression in patients with ALS.
Groeneveld GJ; van Kan HJ; Lie-A-Huen L; Guchelaar HJ; van den Berg LH
Clin Pharmacol Ther; 2008 May; 83(5):718-22. PubMed ID: 17898704
[TBL] [Abstract][Full Text] [Related]
13. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.
Nygren I; Antonova K; Mattsson P; Askmark H
Acta Neurol Scand; 2005 Mar; 111(3):180-4. PubMed ID: 15691287
[TBL] [Abstract][Full Text] [Related]
14. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
Dib M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
[TBL] [Abstract][Full Text] [Related]
15. Motor cortex abnormalities in amyotrophic lateral sclerosis with transcranial direct-current stimulation.
Quartarone A; Lang N; Rizzo V; Bagnato S; Morgante F; Sant'angelo A; Crupi D; Battaglia F; Messina C; Girlanda P
Muscle Nerve; 2007 May; 35(5):620-4. PubMed ID: 17221883
[TBL] [Abstract][Full Text] [Related]
16. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
Vucic S; Cheah BC; Kiernan MC
Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
[TBL] [Abstract][Full Text] [Related]
17. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
Wicks P; Ganesalingham J; Collin C; Prevett M; Leigh NP; Al-Chalabi A
Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
[TBL] [Abstract][Full Text] [Related]
18. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
Yanagisawa N; Shindo M
Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
[TBL] [Abstract][Full Text] [Related]
19. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety of riluzole in amyotrophic lateral sclerosis.
Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]